{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:02:01Z","timestamp":1793916121624,"version":"4.8.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Dysregulated tyrosine kinases in myeloid\/lymphoid neoplasms with eosinophilia are rare, but do occur in children. To increase awareness of this diagnosis, we present a child who was diagnosed after a 3-year disease history. The patient was initially treated according to a T-cell lymphoblastic lymphoma protocol, but genetic analyses at recurrence revealed microdeletions resulting in an in-frame fusion of <jats:italic toggle=\"yes\">ZMYM2<\/jats:italic> and <jats:italic toggle=\"yes\">FLT3<\/jats:italic>. Treatment with sorafenib, an FLT3 tyrosine kinase inhibitor, rapidly resulted in significant reduction of lymphadenopathy and normalization of white blood cell and eosinophil counts. At 17 months of treatment, he remains in complete hematologic, but not molecular remission.<\/jats:p>","DOI":"10.1097\/mph.0000000000001890","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:04:52Z","timestamp":1598483092000},"page":"e508-e511","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Partial Response to Sorafenib in a Child With a Myeloid\/Lymphoid Neoplasm, Eosinophilia, and a ZMYM2-FLT3 Fusion"],"prefix":"10.1097","volume":"43","author":[{"given":"Monica C.","family":"Munthe-Kaas","sequence":"first","affiliation":[{"name":"Paediatric Haematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakel B.","family":"Forthun","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atle","family":"Brendehaug","sequence":"additional","affiliation":[{"name":"Medical Genetics, Haukeland University Hospital, Bergen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette K.","family":"Eek","sequence":"additional","affiliation":[{"name":"Section of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital Trust, Skien"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trude","family":"H\u00f8ys\u00e6ter","sequence":"additional","affiliation":[{"name":"Medicine"},{"name":"Medical Genetics, Haukeland University Hospital, Bergen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv T.N.","family":"Osnes","sequence":"additional","affiliation":[{"name":"Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Prescott","sequence":"additional","affiliation":[{"name":"Section of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital Trust, Skien"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Spetalen","sequence":"additional","affiliation":[{"name":"Pathology, Oslo University Hospital, Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Hovland","sequence":"additional","affiliation":[{"name":"Medical Genetics, Haukeland University Hospital, Bergen"},{"name":"Department of Biosciences, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/leu.2017.240","article-title":"Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia","volume":"31","author":"Jawhar","year":"2017","journal-title":"Leukemia"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/gcc.22477","article-title":"Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients","volume":"56","author":"Busse","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.24148","article-title":"Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib","volume":"59","author":"Abraham","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000495687","article-title":"Sustained response to imatinib in a pediatric patient with concurrent myeloproliferative disease and lymphoblastic lymphoma associated with a CCDC88C-PDGFRB fusion gene","volume":"141","author":"Bielorai","year":"2019","journal-title":"Acta Haematol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2019.06.011","article-title":"Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia","volume":"141","author":"Weis","year":"2019","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:12:53Z","timestamp":1754338373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001890","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"2020-03-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}